Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacy business

Competition watchdog considers Lloydspharmacy’s acquisition of Sainsbury’s pharmacies

The UK’s competition watchdog is looking at the proposed acquisition of Sainsbury’s pharmacy business by Lloydspharmacy on the grounds that it may “reduce market competition”. In the image, storefront of Lloyds Pharmacy

Source: Bigred / Alamy Stock Photo

The Competition and Markets Authority is investigating what impact Lloydspharmacy’s proposed acquisition of Sainsbury’s pharmacies would have on the community pharmacy market

The UK’s competition watchdog is looking at the proposed acquisition of Sainsbury’s pharmacy business by Lloydspharmacy on the grounds that it may “reduce market competition”.

The Competition and Markets Authority (CMA) made the announcement on 9 September 2015 and is inviting comments on the proposed business deal to help inform its decision.

The CMA move comes two months after Lloydspharmacy — part of Celesio AG — and Sainsbury’s revealed their acquisition plans, which they hope to introduce by February 2016.

Under the deal, Lloydspharmacy — the UK’s second largest retail pharmacy company with more than 1,500 stores — will pay annual rent to Sainsbury’s for each of its 277 in-store pharmacies. It will also acquire four Sainsbury’s pharmacies located in hospitals as part of the new business plan worth £125m. All pharmacies will be rebranded as Lloydspharmacy.

The CMA — which has the power to intervene if it believes the proposals would damage market competition — is inviting comments until 23 September 2015. Its investigation will consider whether the proposals would in practice be a “merger” and the impact it would have on the community pharmacy market.

The CMA expects to make its decision on 11 November 2015.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069370

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The UK’s competition watchdog is looking at the proposed acquisition of Sainsbury’s pharmacy business by Lloydspharmacy on the grounds that it may “reduce market competition”. In the image, storefront of Lloyds Pharmacy

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.